Intuitive Surgical Gets FDA OK for Latest Robotic System
By Ben Glickman
Intuitive Surgical said Thursday it received approval from U.S. regulators for its latest robotic system for surgery, the da Vinci 5.
The Sunnyvale, Calif.-based company said the U.S. Food and Drug Administration cleared its 510(k) form, allowing Intuitive to bring its product to market.
The company's new multiport robotic system will first be available to a small number of customers in the U.S. who worked with the company during development. Intuitive said it would generate additional data on the system before a wider commercial rollout.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
March 14, 2024 17:02 ET (21:02 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters